HEALTH UPDATES
New measles cases tied to N.J. patient who visited 3 health facilities. Updated: Feb. 27, 2025, 10:16 a.m. |Published: Feb. 27, 2025, 7:02 a.m. New Jersey health officials have confirmed two additional cases of measles in the state this year linked to a Bergen County resident who recently traveled internationally. The initial case was reported Feb. 14 in an unvaccinated person.
The state Department of Health officials warned that the person may have exposed others during a visit to the emergency department at Englewood Hospital in Bergen County, Feb. 9 between 11:30 a.m. and 5:30 p.m. Two additional cases had been identified, both involving individuals who had close contact with the original patient, health officials said.
The original patient may have also spread the virus at Hackensack University Medical Center and an urgent care facility in Fort Lee. A spokesperson for the Hackensack hospital said the patient, a child with measles, was transferred from another hospital and immediately placed into isolation.
The two new cases also involved unvaccinated people, state officials said. The state health department is working with local health agencies to track any possible exposures and notify individuals who may have been in contact with the infected patients when they were contagious.
The department is urging residents to check vaccination records and ensure they are up to date, particularly for the measles-mumps-rubella vaccine, which provides protection against the highly contagious virus.
New Jersey residents can verify their immunization records using the Docket App, which provides access to information stored in the New Jersey Immunization Information System. Vaccination records may also be available through healthcare providers, former schools, colleges, employers, the military, or obstetricians' offices. The outbreak in New Jersey comes amid a surge in measles cases across the United States.
Given the global spread of measles, New Jersey health officials strongly advises all residents planning to travel—regardless of destination—to ensure they are fully vaccinated. The measles-mumps-rubella vaccine is recommended for all travelers, particularly those visiting international locations where measles is more prevalent.
A child, unvaccinated, died in a measles outbreak in rural West Texas, the first U.S. death from the highly contagious, but preventable, respiratory disease since 2015, according to state officials.
As of Feb. 20, a rash of 124 cases has erupted across nine counties. The Centers for Disease Control and Prevention, CDC, reported a total of 93 measles cases in Alaska, California, Georgia, New Jersey, New Mexico, New York City, Rhode Island, and Texas.
For parents traveling with infants 6 to 11 months, health officials recommend consulting a pediatrician about receiving an early dose of the measles-mumps-rubella vaccine before departure.
Measles is a highly contagious virus that spreads through the air when an infected person coughs or sneezes. Symptoms typically appear 7 to 14 days after exposure and include:
Severe complications can include: pneumonia, encephalitis (swelling of the brain), and in rare cases, death.
Measles Outbreaks in U.S. Are Growing: How to Protect Yourself. Feb. 21, 2025. Cases of measles are rising across the United States, with the largest outbreak reported in Texas. The Texas Department of State Health Services says 90 cases have been discovered in the South Plains region of the state since late January, with 16 patients needing hospitalization.
Gaines County has reported 57 cases, the highest number in the state so far. In Lea County, New Mexico, which borders Gaines County, has reported eight cases of measles, according to New Mexico Department of Health. Alaska, Georgia, New York City, and Rhode Island have also reported measles cases this year.
Measles is a highly contagious disease that appears to be making a comeback as vaccination rates across the U.S. decline. In Texas, only five of the patients had been vaccinated for measles, the state health services department says.
Measles is a contagious virus that mainly affects babies and young children. Learn about how it spreads, dangerous complications, and the vaccine. Health experts agree, vaccination is the best way to avoid getting measles. The CDC says that two doses of the measles, mumps, and rubella (MMR) vaccine is 97% effective against measles.
The CDC also recommends all children receive two doses of the MMR vaccine,
It’s not only children who need the vaccine. Adults who don’t have presumptive evidence of immunity should get at least one dose of the MMR vaccine, the CDC says. Some need two doses - who are in post-secondary educational settings, work in health care, have contact with immunocompromised people, or travel internationally.
Evidence of immunity is documentation that you’ve been vaccinated for measles or have tested positive for measles IgG antibodies or for the disease. Generally, adults born before 1957 are considered immune to measles and don’t need a booster.
Adults born in 1957 or later should get at least one dose of the MMR vaccine. Adults who were previously given a vaccine in the 1960s made with “killed” measles, as opposed to the live-type vaccine used today, or were given an MMR vaccine between 1963-1967 but there’s no record of what type of vaccine.
Because of the risk of birth defects, all women of childbearing age should have the MMR vaccine unless they're pregnant, have proof of immunity, or have proof of being vaccinated for rubella.
Measles cases could exceed the number reported in 2024 (285), which easily topped the number in 2023 (59), the CDC says.
FDA outbreak investigation continues. Coral Beach, February27, 2025. The Food and Drug Administration continues to investigate four foodborne illness outbreaks, two from Salmonella and two from Listeria monocytogenes.
The outbreak is linked to Sweet Cream-brand mini pastries manufactured in Italy and exported into the United States by Importations Piu Che Dolci Inc. of Quebec, Canada. The outbreak began in Canada where 69 patients are reported sick. The pastries have been recalled in both countries. The FDA first posted the outbreak on Feb. 5.
The shakes were produced by Prairie Farms Dairy Inc. at its facility in Fort Wayne, IN. The FDA found Listeria monocytogenes in the facility. The FDA first heard of the outbreak in October 2024, posting as being of unknown origin in Dec. 26, 2024. It announced the cause on Feb. 21.
CDC warns of Listeria outbreak linked to supplement shakes distributed in long-term care facilities. Media alert - For immediate release: February 24, 2025
CDC Media Relations
(404) 639-3286
A CDC food safety alert regarding a multistate outbreak of Listeria infections has been posted: https://www.cdc.gov/listeria/outbreaks/shakes-022025/index.html
Key Points:
What You Should Do:
What Businesses Should Do:
Listeria Symptoms:
Listeria is especially harmful to women who are pregnant, those aged 65 years or older, or those with weakened immune systems causing a severe condition known as invasive listeriosis.
Symptoms usually start within 2 weeks after eating food contaminated with Listeria but may start as early as the same day or as late as 10 weeks after.
For more information about Listeria, see the Listeria homepage.
If you have questions about cases in a particular state, please call that state's health department.
VARIANT UPDATES
Is Another Pandemic On The Horizon? All You Need to Know About Deadly HKU5-CoV-2 COVID-19 Variant Detected In China. MSNBC. New China COVID Variant News. Four years after the first case of the COVID-19 virus was reported from China's Wuhan city, the world is once again on the verge of witnessing another pandemic outbreak.
According to the report, experts issued a high alert after Chinese scientists revealed that they have detected another highly infectious COVID-19 variant -- HKU5-CoV-2 in bats, capable of evading the human immunity system.
The main reason for global concern is the possibility of human transmission. No human infections have been confirmed, but the virus's ability to infect laboratory-cultured human cells is alarming. The HKU5-CoV-2 variant possesses mutations that might allow it to partially evade the immune system. This raises fears about the effectiveness of existing COVID-19 vaccines and the potential need for updated formulations, experts told media.
Thailand Health Officials Respond to Newly Detected HK5-CoV-2 COVID-19 Variant.
Responding to the detection of HKU5-CoV-2 in bats in China, Thailand's disease surveillance network , which comprises: the Department of Disease Control, Department of Medical Sciences, and university researchers,. Their specialized team is closely monitoring the variant and remains vigilant of any potential outbreak. Officials also stressed that HKU5-CoV-2 is a variant within an existing viral family rather than a new strain or mutation.
HKU5-CoV-2 COVID. MSNBC. TheHealthSite.com. HKU5-CoV-2 Coronavirus Variant: Chinese researchers, led by virologist Shi Zhengli, discovered a new bat coronavirus that poses potential risks of animal-to-human transmission, sparking concerns of future spillover events. The virus, identified as HKU5-CoV-2, belongs to the merbecovirus subgenus, which includes the MERS virus.
According to initial reports, this newly isolated strain can bind to the ACE2 receptor in human cells, the same pathway used by the Covid-19 virus.
No human cases have been reported so far associated with this newly detected variant of coronavirus.
Symptoms of This New Bat Coronavirus. There are no confirmed cases of HKU5-CoV-2 in humans yet, so symptoms are unknown. However, it belongs to the same subgenus as MERS and COVID-19 and might cause similar respiratory symptoms, such as: fever, cough, shortness of breath, sore throat, fatigue and body aches.
VACCINE UPDATES
COVID-19. Staying Up to Date with COVID-19 Vaccines. January 7, 2025
CDC’s website is being modified to comply with President Trump’s Executive Orders.
What to know
Importance of staying up to date
When are you up to date?
If your child previously had: |
Your child should get: |
---|---|
0 doses (was never vaccinated) |
2 doses of the 2024–2025 Moderna vaccine OR 3 doses of the 2024–2025 Pfizer-BioNTech vaccine |
1 or more doses of Moderna vaccine |
1 dose of the 2024–2025 Moderna vaccine |
1 dose of Pfizer-BioNTech vaccine |
2 doses of the 2024–2025 Pfizer-BioNTech vaccine |
2 or more doses of Pfizer-BioNTech vaccine |
1 dose of the 2024–2025 Pfizer-BioNTech vaccine |
Recommended COVID-19 Vaccines. Three vaccines are available for use in the United States. There is no preference for one vaccine over the other when more than one vaccine is recommended for an age group.
The 2024–2025 COVID-19 vaccines more closely target the JN.1 lineage of the Omicron variant.
2024–2025 vaccines are updated to give you the best protection from the currently circulating strains.
Vaccine |
Recommended for: |
---|---|
2024–2025 Moderna COVID-19 Vaccine |
Everyone ages 6 months and older |
2024–2025 Pfizer-BioNTech COVID-19 Vaccine |
Everyone ages 6 months and older |
2024–2025 Novavax COVID-19 Vaccine |
Everyone ages 12 years and older |
How to Protect Yourself? Getting vaccinated is your best bet!
IT’S NOT OVER!
Stay safe. Mask. Social distance. Frequent hand washing. Avoid crowds
ALWAYS CONSULT YOUR PERSONAL HEALTH CARE PROFESSIONAL
<< New text box >>